NDC00143-9681-25 — GLYCOPYRROLATE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00143-9681-25: GLYCOPYRROLATE INJECTION.

The GLYCOPYRROLATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: VIAL, supplementary_features: NOTE: F, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-250-5715, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00143-9681-25

NSN: 6505-01-250-5715
FSC: 6505 — Drugs and Biologicals
CAGE: 32655 — HIKMA PHARMACEUTICALS USA INC. (USA)

SPECIFICATIONS

special_features	EACH SINGLE-DOSE VIAL ALSO CONTAINS BENZYL ALCOHOL,0.9 PCT PER ML,AND WATER FOR INJECTION IN A SUFFICIENT AMOUNT PER ML; PH ADJUSTED WITH SODIUM HYDROXIDE AND/OR HYDROCHLORIC ACID IF REQUIRED
primary_container_type	VIAL
supplementary_features	NOTE: F
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	25
primary_container_content_quantity	2.000 MILLILITERS
active_medicament_medicinal_strength	0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER
part_name_assigned_by_controlling_agency	GLYCOPYRROLATE INJECTION USP 2ML VIAL 25S PG
NSN	6505-01-250-5715

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS

•

SUPPLEMENTARY FEATURES: NOTE: F

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER

•

TOTAL PRIMARY CONTAINER QUANTITY: 25

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	2.000 MILLILITERS
SUPPLEMENTARY FEATURES	NOTE: F
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	EACH SINGLE-DOSE VIAL ALSO CONTAINS BENZYL ALCOHOL,0.9 PCT PER ML,AND WATER FOR INJECTION IN A SUFFICIENT AMOUNT PER ML; PH ADJUSTED WITH SODIUM HYDROXIDE AND/OR HYDROCHLORIC ACID IF REQUIRED
PART NAME ASSIGNED BY CONTROLLING AGENCY	GLYCOPYRROLATE INJECTION USP 2ML VIAL 25S PG
ACTIVE MEDICAMENT MEDICINAL STRENGTH	0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY	25

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 2

NDC63323-0578-02Same NSN cross-reference

Same NSN cross-reference

Also cataloged under this NSN

NDC00031-7890-95Reference document

Same NSN cross-reference

Reference document — Design control — primary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedNo demilitarization required

Ready to buy NDC00143-9681-25?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00143-9681-25?

NDC00143-9681-25 is a GLYCOPYRROLATE INJECTION.

What parts can replace NDC00143-9681-25?

There are 2 known substitutes for NDC00143-9681-25: NDC63323-0578-02, NDC00031-7890-95. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00143-9681-25?

NDC00143-9681-25 is cataloged in the U.S. Government catalog under NSN 6505-01-250-5715. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00143-9681-25 — GLYCOPYRROLATE INJECTION

Request a Quote — NDC00143-9681-25